Effects of decomplementation with cobra venom factor on experimental vasculitis

Mercuric chloride (HgCl2) induces autoimmunity in susceptible rat strains, with hyper‐IgE, appearance of a number of autoantibodies and wide spread tissue injury, including necrotizing vasculitis in the gut. In the early phase of tissue injury there is granulocyte infiltration; later there is immunoglobulin deposition along basement membranes in vessels. We have analysed the role of complement in this model using cobra venom factor (CVF). which causes decomplementation lasting around 5 days. The characteristic time course when HgCl2 is given over 10 days is that tissue injury and autoantibody levels reach a peak at around day 15 (start of HgCl2= day 0). We therefore gave CVF either early (day 0). intermediate (day 5) or late (day 10); a fourth group (controls) received HgCl2 but no CVF. At each time point, CVF caused complete decomplementation which lasted for al least 5 days, Serum IgE and autoantibody levels were similar in all four experimental groups. Tissue injury in the “early” CVF group and in the ‘Jale’ CVF group was not significantly different from control, but in the intermediate group tissue injury was significantly more severe than in controls. These data indicate that the complement system does not play a major rote in the induction of autoantibodies by HgCl2, nor in the effector phase of tissue injury. We speculate that the exacerbation of tissue injury by CVF in the group given this agent al an intermediate stage of the model is explained by the presence of products of C3 activation which have proinflammatory effects during the phase of active granulocyte‐mediated tissue injury.

[1]  Mathieson Pw,et al.  Deficiency and depletion of complement in the pathogenesis of nephritis and vasculitis. , 1993 .

[2]  S. Thiru,et al.  Regulatory role of OX22high T cells in mercury-induced autoimmunity in the brown Norway rat , 1993, The Journal of experimental medicine.

[3]  P. Mathieson,et al.  Deficiency and depletion of complement in the pathogenesis of nephritis and vasculitis. , 1993, Kidney international. Supplement.

[4]  D. Flint,et al.  Mechanism of action of cytotoxic antibodies to adipocytes on adipose tissue, liver and food intake in the rat. , 1992, International journal of obesity and related metabolic disorders : journal of the International Association for the Study of Obesity.

[5]  S. Thiru,et al.  Mercuric chloride-treated brown Norway rats develop widespread tissue injury including necrotizing vasculitis. , 1992, Laboratory investigation; a journal of technical methods and pathology.

[6]  S. Thiru,et al.  Autoantibodies to myeloperoxidase in brown Norway rats treated with mercuric chloride. , 1992, Laboratory investigation; a journal of technical methods and pathology.

[7]  D. Fearon ANTI‐INFLAMMATORY AND IMMUNOSUPPRESSIVE EFFECTS OF RECOMBINANT SOLUBLE COMPLEMENT RECEPTORS , 1991, Clinical and experimental immunology.

[8]  G. Füst,et al.  The role of C3 in the immune response. , 1991, Immunology today.

[9]  P. Mathieson,et al.  Immunoregulation of mercuric chloride‐induced autoimmunity in Brown Norway rats: A role for CD8+ T cells revealed by in vivo depletion studies , 1991, European journal of immunology.

[10]  M. Goldman,et al.  TH2 cells in systemic autoimmunity: insights from allogeneic diseases and chemically-induced autoimmunity. , 1991, Immunology today.

[11]  J. Gergely,et al.  Interaction between C3 and IL-2; inhibition of C3b binding to CR1 by IL-2. , 1989, Immunology letters.

[12]  R. Coffman,et al.  Heterogeneity of cytokine secretion patterns and functions of helper T cells. , 1989, Advances in immunology.

[13]  H. Yssel,et al.  Antigen-bound C3b and C4b enhance antigen-presenting cell function in activation of human T-cell clones. , 1988, Immunology.

[14]  P. Hultman,et al.  Mercury induced antinuclear antibodies in mice: characterization and correlation with renal immune complex deposits. , 1988, Clinical and experimental immunology.

[15]  G. Klaus,et al.  A re-evaluation of the role of C3 in B-cell activation. , 1986, Immunology today.

[16]  P. Verroust,et al.  Mercuric chloride induced autoimmune disease in Brown‐Norway rats: sequential search for anti‐basement membrane antibodies and circulating immune complexes , 1982, European journal of clinical investigation.

[17]  J. Bernaudin,et al.  Extrarenal immune complex type deposits induced by mercuric chloride in the Brown Norway rat. , 1979, Clinical and experimental immunology.

[18]  D. Evans,et al.  Prolonged complement activation in mice. , 1978, Kidney international.

[19]  P. Druet,et al.  Induction of anti-glomerular basement membrane antibodies in the Brown-Norway rat by mercuric chloride. , 1977, Clinical and experimental immunology.

[20]  M. Pepys ROLE OF COMPLEMENT IN INDUCTION OF ANTIBODY PRODUCTION IN VIVO , 1974, The Journal of experimental medicine.

[21]  J. Bariéty,et al.  Glomerulonephritis with - and 1C-globulin deposits induced in rats by mercuric chloride. , 1971, The American journal of pathology.